MK-677 increased IGF-1 in beagle dogs not only by stimulating GH release but also through GH-independent mechanisms, and cortisol increases were driven by a direct adrenal effect rather than ACTH.
Dual IGF-1 mechanismMK-677 raises IGF-1 not just through GH stimulation but also through a GH-independent pathway, and cortisol rises from direct adrenal effects
What the researchers found
MK-677 increased IGF-1 through both GH-dependent and GH-independent mechanisms, and elevated cortisol through direct adrenal stimulation rather than ACTH, revealing multi-target pharmacology beyond simple GH secretagogue activity.
Why it matters
Understanding MK-677's full pharmacology is essential for predicting clinical effects and side effects. The GH-independent IGF-1 increase and direct adrenal cortisol stimulation were unexpected and have implications for long-term use.
How the study worked
Animal study in beagle dogs. Oral MK-677 effects on GH, IGF-1, cortisol, and ACTH were measured. GH-blocking experiments and ACTH measurements were used to dissect the mechanisms of IGF-1 and cortisol elevation.
What this study cannot tell us
Beagle dog pharmacology may differ from humans. The GH-independent IGF-1 mechanism was not identified. Chronic dosing effects not assessed.
How to read the evidence
Moderate evidence from a well-designed mechanistic animal study in beagle dogs with specific blocking experiments to dissect pathways.
When this study was published
Published in 1999. MK-677's multi-target mechanisms continue to be relevant for understanding its effects in humans.
The bigger picture
Drug mechanisms are often more complex than initially assumed. MK-677's multi-target effects highlight the importance of thorough pharmacological characterization before widespread clinical use.
Questions still open
- What is the GH-independent pathway for MK-677's IGF-1 increase?
- Does the direct adrenal effect cause clinically significant cortisol elevation in humans?
- Do these multi-target mechanisms differ between species?
Common questions
Does MK-677 only work through growth hormone?
Should people be concerned about the cortisol increase?
Read the original research
Increases in circulating insulin-like growth factor I levels by the oral growth hormone secretagogue MK-0677 in the beagle are dependent upon pituitary mediation.
Endocrinology, 140(4), 1552-8
Citation
Schleim, K D; Jacks, T; Cunningham, P; Feeney, W; Frazier, E G; Niebauer, G W; Zhang, D; Chen, H; Smith, R G; Hickey, G. (1999). Increases in circulating insulin-like growth factor I levels by the oral growth hormone secretagogue MK-0677 in the beagle are dependent upon pituitary mediation.. Endocrinology, 140(4), 1552-8.